India Globalization Capital Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IGC | CASI | ENLV | ||
| Company | India Globalization Capital Inc | Casi Pharmaceuticals Inc | Enlivex Therapeutics Ltd | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 0.4720 | 2.37 | 1.4700 | ||
| High | 0.4748 | 2.39 | 1.8400 | ||
| Low | 0.4200 | 2.28 | 1.4700 | ||
| Last | 0.4632 | 2.34 | 1.6600 | ||
| Change | +0.0052 | -0.08 | +0.2200 | ||
| % Change | +1.14% | -3.31% | +15.28% | ||
| Volume | 436,500 | 4,100 | 477,400 | ||
| 20-Day Average Volume | 1,677,000 | 35,620 | 378,445 | ||
| Previous Close | 0.4580 | 2.42 | 1.4400 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5191 | 2.69 | 2.3635 | ||
| 20-Day Raw Stochastic | 12.39% | 18.12% | 14.83% | ||
| 20-Day Relative Strength | 51.54% | 33.22% | 37.53% | ||
| Weighted Alpha | +17.04 | -43.58 | -37.61 | ||
| Today's Opinion | 88% Buy | 88% Sell | 40% Sell | ||
| Previous Opinion | 88% Buy | 88% Sell | 24% Sell | ||
| Last Month's Opinion | 56% Buy | 56% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.07% since 04/22/24 | -3.70% since 04/22/24 | +30.71% since 04/22/24 | ||
| Low | 0.4130 on 04/24/24 | 2.22 on 04/25/24 | 1.3000 on 04/23/24 | ||
| High | 0.4960 on 04/26/24 | 2.61 on 04/25/24 | 1.8400 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | +15.80% since 03/28/24 | -35.18% since 03/28/24 | -56.20% since 03/28/24 | ||
| Low | 0.4000 on 04/15/24 | 2.05 on 04/17/24 | 1.1500 on 04/15/24 | ||
| High | 0.9099 on 04/04/24 | 3.69 on 04/01/24 | 4.5900 on 04/03/24 | ||
| 3-Month | |||||
| %Chg | +64.78% since 01/29/24 | -64.60% since 01/29/24 | -34.65% since 01/29/24 | ||
| Low | 0.2700 on 02/22/24 | 2.05 on 04/17/24 | 1.1500 on 04/15/24 | ||
| High | 0.9099 on 04/04/24 | 7.19 on 02/01/24 | 4.5900 on 04/03/24 | ||
| 6-Month | |||||
| %Chg | +59.61% since 10/27/23 | -35.89% since 10/27/23 | +24.81% since 10/27/23 | ||
| Low | 0.2501 on 12/20/23 | 2.05 on 04/17/24 | 1.1500 on 04/15/24 | ||
| High | 0.9099 on 04/04/24 | 8.48 on 12/12/23 | 4.5900 on 04/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,948 | 31,358 | 30,820 | ||
| Shares Outstanding, K | 66,813 | 13,401 | 18,566 | ||
| Annual Sales | 910,000 | 33,880,000 | 0 | ||
| Annual Net Income | -11,510,000 | -26,940,000 | -29,070,000 | ||
| Last Quarter Sales | 200,000 | 6,030,000 | 0 | ||
| Last Quarter Net Income | -5,590,000 | -5,480,000 | -9,100,000 | ||
| 60-Month Beta | 1.71 | N/A | 1.02 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.09 on 02/14/24 | -0.29 on 03/28/24 | -0.48 on 03/29/24 | ||
| Latest Earnings Date | 02/13/24 | 05/15/24 | 06/21/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||